Nima Nabavizadeh, MD is an associate professor of radiation medicine and chief medical officer at the Cancer Early Detection Advanced Research Center at Oregon Health & Science University (OHSU), Portland. Dr. Nabavizadeh has served as the principal investigator for many multi-cancer early detection clinical trials, including the Pathfinder-2 study. Dr. Nabavizadeh has previously served as a consultant to GRAIL, Freenome and SAI-Med Partners. OHSU.edu
Every year, more than 600,000 Americans die from cancer. But here’s an equally disturbing statistic—seven out of 10 of those deaths are from cancers that...
